MedTrace Logo

Growth and Tolerance of Young Infants Fed Infant Formulas

NCT01380886 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 209

Last updated 2013-02-15

No results posted yet for this study

Summary

This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.

Conditions

  • Infant Newborn

Interventions

OTHER

experimental infant formula with alternate protein source

experimental infant formula to be fed ad libitum

OTHER

Infant formula powder

powdered infant formula to be fed ad libitum

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Marlene Borschel, PhD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
8 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01380886 on ClinicalTrials.gov